0001209191-17-007757.txt : 20170203
0001209191-17-007757.hdr.sgml : 20170203
20170203173615
ACCESSION NUMBER: 0001209191-17-007757
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170201
FILED AS OF DATE: 20170203
DATE AS OF CHANGE: 20170203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYNOSURE INC
CENTRAL INDEX KEY: 0000885306
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 043125110
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 CARLISLE ROAD
CITY: WESTFORD
STATE: MA
ZIP: 01886
BUSINESS PHONE: (978) 256-4200
MAIL ADDRESS:
STREET 1: 5 CARLISLE ROAD
CITY: WESTFORD
STATE: MA
ZIP: 01886
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davin Michael R
CENTRAL INDEX KEY: 0001345975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51623
FILM NUMBER: 17573296
MAIL ADDRESS:
STREET 1: C/O CYNOSURE, INC.
STREET 2: 5 CARLISLE ROAD
CITY: WESTFORD
STATE: MA
ZIP: 01886
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-01
0
0000885306
CYNOSURE INC
CYNO
0001345975
Davin Michael R
C/O CYNOSURE, INC.
5 CARLISLE ROAD
WESTFORD
MA
01886
1
1
0
0
Chairman, President and CEO
Class A Common Stock
2017-02-01
4
A
0
10118
0.00
A
29235
D
Class A Common Stock
2017-02-03
4
F
0
5111
50.0998
D
24124
D
On February 1, 2017, 10,118 shares that were acquired by the reporting person pursuant to the award of the performance-based stock units vested and were paid to the reporting person. On February 3, 2017, 5,111 of these 10,118 shares were withheld and sold in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to pay the resulting tax liability.
The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $50.03 to $51.03 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Christopher J. Geberth, Attorney-in-Fact
2017-02-03